Reuters logo
BRIEF-Cipla exec expects to file for approval of more than 20 products in the U.S. in FY18
May 25, 2017 / 12:04 PM / 6 months ago

BRIEF-Cipla exec expects to file for approval of more than 20 products in the U.S. in FY18

May 25 (Reuters) - Cipla Ltd:

* Cipla exec says remodelling Cipla Biotec towards an in-licensing structure

* Cipla exec says plan to be very active on in-licensing opportunities

* Cipla exec says expects to file for approval of more than 20 products in the U.S. in FY18

* Cipla exec says memorandum of understanding signed for a South Africa plant signed last year is on hold

* Cipla exec says expects volatility in India market in coming months due to GST Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below